Muscadine Plus (MPX) In Men With Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Channing Paller, M.D
SKCCC at Johns Hopkins
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- University of Chicago
Chicago, Illinois, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- Allegheny Health Network
Pittsburgh, Pennsylvania, United States
- Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2018
- Primary completion
- 6 Jul 2022
- Completion
- 3 Nov 2022
- Last update posted
- 22 May 2023
- Registered enrollment
- 59
- Registry id
- NCT03535675
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.